| Name | | |
| Last NAV | 105.88 | 51.69 |
| Date of Valuation | 2025/10/28 | 2025/10/28 |
| Sharpe Ratio | 0.76 | N/A |
| 3-Year Risk Return Ratio | 1.11 | 1.03 |
| Cumulative Performance (%) |
| +13.76% | +11.19% |
| +20.06% | +27.13% |
| +58.53% | +36.82% |
| +77.68% | +31.69% |
| +14.80% | +17.29% |
| +6.50% | -17.36% |
| +8.60% | +33.53% |
| N/A | +416.90% |
| Calendar Year Performance (%) |
| +14.80% | +17.29% |
| -29.90% | -12.51% |
| +6.50% | -17.36% |
| +39.40% | +27.52% |
| +8.60% | +33.53% |
| 3-Year Annualised Volatility | 21.25% | 16.91% |
| Funds House | J.P. Morgan Asset Management | Franklin Templeton Investments (Asia) Ltd |
| Portfolio Manager | John Cho & Chun Yu Wong | Evan McCulloch & Wendy Lam & Akiva Felt |
| Funds Type | Equity Funds | Equity Funds |
| Funds Size | USD 179000000 | USD 1590000000 |
| Base Currency | USD | USD |
| Sector | General | Biotechnology |
| Geographic Allocation | Korea | US |
| Top Holdings |
| Samsung Electronics (9.80%) | AMGEN INC (8.16%) |
| SK hynix (8.40%) | REGENERON PHARMACEUTICALS INC (7.13%) |
| LG Chem (3.60%) | VERTEX PHARMACEUTICALS INC (5.83%) |
| Hyundai Motor (3.20%) | INSMED INC (3.82%) |
| SAMSUNG C&T (3.20%) | GILEAD SCIENCES INC (3.69%) |
| NAVER (2.90%) | ASTRAZENECA PLC (2.92%) |
| SAMSUNG BIOLOGICS (4.60%) | INTRA-CELLULAR THERAPIES INC (2.84%) |
| Samsung Electro-Mechanics (2.50%) | BIOGEN INC (2.74%) |
| Hana Financial Group (3.40%) | MERUS NV (2.73%) |
| Shinhan Financial Group (2.80%) | ARGENX SE (2.68%) |
| Minimum Initial Investment | USD 1000 | USD 1000 |
| Initial Sales Fee | 5.0% of NAV | Class A: Up to 5.00%. Class B: Nil |
| Switching Fee | 1.0% of NAV | Class A: 1.00%. Class B: Nil |
| Maintenance Fee | Trustee fee:0.03%–0.125% of NAV p.a. (maximum 0.2%; subject to the NAV and a minimum of USD 12,500 p.a.) | Custodian fee Class A: Up to 0.14% ( As the investment objectives and policies of this fund provide for investments in equity securities of issuers in developing countries, there may be higher possible custodian annual fees for this fund.). Custodian fee Class B: Up to 0.14%( As the investment objectives and policies of this fund provide for investments in equity securities of issuers in developing countries, there may be higher possible custodian annual fees for this fund.). Maintenance charge Class A: Up to 0.50%. Maintenance charge Class B: Up to 0.75%. Servicing charge Class A: Nil. Servicing charge Class B: 1.06%. Registrar and Transfer, Corporate, Domiciliary and Administrative Agent fee + Additional fixed amount of USD per Shareholder account at the relevant Class level Class A: Up to 0.2175%, Up to USD 30 per annum. Registrar and Transfer, Corporate, Domiciliary and Administrative Agent fee + Additional fixed amount of USD per Shareholder account at the relevant Class level Class B: Up to 0.2175%, Up to USD 30 per annum. |
| Redemption Fee | 0.5% of NAV | Class A: Nil. Class B: Up to 4.00% |
| Launch Date | 1991/12/11 | 2000/04/03 |
| End of Financial Year | 30/09 | 30/06 |
| Country of Registry | Hong Kong | Luxembourg |
| Other Relevant Information | | |
| |